Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2006 Oct;43(10):793-7.
doi: 10.1136/jmg.2006.041517. Epub 2006 Apr 13.

SMAD4 mutations found in unselected HHT patients

C J Gallione  1 , J A Richards, T G W Letteboer, D Rushlow, N L Prigoda, T P Leedom, A Ganguly, A Castells, J K Ploos van Amstel, C J J Westermann, R E Pyeritz, D A Marchuk
Affiliations
Multicenter Study

SMAD4 mutations found in unselected HHT patients

C J Gallione et al. J Med Genet. 2006 Oct.

Abstract

Background: Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disease exhibiting multifocal vascular telangiectases and arteriovenous malformations. The majority of cases are caused by mutations in either the endoglin (ENG) or activin receptor-like kinase 1 (ALK1, ACVRL1) genes; both members of the transforming growth factor (TGF)-beta pathway. Mutations in SMAD4, another TGF-beta pathway member, are seen in patients with the combined syndrome of juvenile polyposis (JP) and HHT (JP-HHT).

Methods: We sought to determine if HHT patients without any apparent history of JP, who were undergoing routine diagnostic testing, would have mutations in SMAD4. We tested 30 unrelated HHT patients, all of whom had been referred for DNA based testing for HHT and were found to be negative for mutations in ENG and ALK1.

Results: Three of these people harboured mutations in SMAD4, a rate of 10% (3/30). The SMAD4 mutations were similar to those found in other patients with the JP-HHT syndrome.

Conclusions: The identification of SMAD4 mutations in HHT patients without prior diagnosis of JP has significant and immediate clinical implications, as these people are likely to be at risk of having JP-HHT with the associated increased risk of gastrointestinal cancer. We propose that routine DNA based testing for HHT should include SMAD4 for samples in which mutations in neither ENG nor ALK1 are identified. HHT patients with SMAD4 mutations should be screened for colonic and gastric polyps associated with JP.

PubMed Disclaimer

Conflict of interest statement

Competing interests: there are no competing interests

References

    1. Begbie M E, Wallace G M, Shovlin C L. Hereditary haemorrhagic telangiectasia (Osler‐Weber‐Rendu syndrome): a view from the 21st century. Postgrad Med J 20037918–24. - PMC - PubMed
    1. McAllister K A, Grogg K M, Johnson D W, Gallione C J, Baldwin M A, Jackson C E, Helmbold E A, Markel D S, McKinnon W C, Murrell J, McCornlich M K, Perieak‐Vanee M A, Heutink P, Oostra B A, Haitjema T, Westermann C J J, Porteous M E, Guttmacher A E, Letarte M, Marchuk D A. Endoglin, a TGF‐beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 19948345–351. - PubMed
    1. Johnson D W, Berg J N, Baldwin M A, Gallione C J, Marondel I, Yoon S J, Stenzel T T, Speer M, Pericak‐Vance M A, Diamond A, Guttmacher A E, Jackson C E, Attisano L, Kucherlapati R, Porteous M E, Marchuk D A. Mutations in the activin receptor‐like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 199613189–195. - PubMed
    1. Lebrin F, Deckers M, Bertolino P, Ten Dijke P. TGF‐beta receptor function in the endothelium. Cardiovasc Res 200565599–608. - PubMed
    1. ten Dijke P, Hill C S. New insights into TGF‐beta‐Smad signalling. Trends Biochem Sci 200429265–273. - PubMed

Publication types